Culture-adapted Plasmodium falciparum isolates from UK travellers: In vitro drug sensitivity, clonality and drug resistance markers

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Van Schalkwyk, Donelly A ^a   Burrow, Rebekah ^a   Henriques, Gisela ^a   Gadalla, Nahla B ^a   Beshir, Khalid B ^a   Hasford, Christian ^b   Wright, Stephen G ^c   Ding, Xavier C ^d   Chiodini, Peter L ^c   Sutherland, Colin J ^a,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^d Medicines for Malaria Venture   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTEROLANE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DIHYDROARTEMISININ; EDETIC ACID;

AFRICA; ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CLINICAL ARTICLE; CLONAL VARIATION; CODON; CONTINUOUS CULTURE; DRUG EXPOSURE; FEMALE; GAMETOCYTE; GENE; GENE LOCUS; HAPLOTYPE; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MALARIA FALCIPARUM; MALE; PARASITE ISOLATION; PFAP2MU GENE; PFCRT GENE; PFDHFR GENE; PFDHPS GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; TREATMENT DURATION; UNITED KINGDOM;

ADULT; AFRICA; ANTIMALARIALS; DRUG RESISTANCE; FEMALE; GREAT BRITAIN; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MALE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; TRAVEL;

EID: 84883683035     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-320     Document Type: Article

References (69)

1. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, Dolecek C, Hien TT, do Rosário VE, Arez AP, Pinto J, Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD, Barnwell JW, Pain A, Williams J, White NJ, Day NP, Snounou G, Lockhart PJ, Chiodini PL, Imwong M, Polley SD, J Infect Dis 2010 201 1544 1550
2. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ, Lancet 2004 363 1017 1024 (Pubitemid 38410774)
3. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675
4. Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes. Molina-Cruz A, DeJong RJ, Ortega C, Haile A, Abban E, Rodrigues J, Jaramillo-Gutierrez G, Barillas-Mury C, Proc Natl Acad Sci USA 2012 109 1957 E1962
5. Plasmodium falciparum is able to invade erythrocytes through a trypsin-resistant pathway independent of glycophorin B. Gaur D, Storry JR, Reid ME, Barnwell JW, Miller LH, Infect Immun 2003 71 6742 6746 (Pubitemid 37475301)
6. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871
7. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, Nature 1990 345 255 258
8. WHO, World Malaria Report 2011 http://www.who.int/malaria/world-malaria- report-2011/en/
9. A 2d patient with tropical malaria contracted in a natural way in the Netherlands. de Delemarre-van Waal HA, de Waal FC, Ned Tijdschr Geneeskd 1981 125 375 377 (Pubitemid 11148773)
10. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Ponnudurai T, Leeuwenberg AD, Meuwissen JH, Trop Geogr Med 1981 33 50 54 (Pubitemid 11091208)
11. Genetic analysis of the human malaria parasite Plasmodium falciparum. Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, Corcoran LM, Burkot TR, Carter R, Science 1987 236 1661 1666 (Pubitemid 17091020)
12. Characterization of an S antigen synthesized by several isolates of Plasmodium falciparum. Anders RF, Brown GV, Edwards A, Proc Natl Acad Sci U S A 1983 80 6652 6656 (Pubitemid 14240153)
13. Gametocyte-forming and non-gametocyte-forming clones of Plasmodium falciparum. Bhasin VK, Trager W, Am J Trop Med Hyg 1984 33 534 537 (Pubitemid 14053343)
14. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Oduola AM, Weatherly NF, Bowdre JH, Desjardins RE, Exp Parasitol 1988 66 86 95
15. Cloning of naturally occurring mixed infections of malaria parasites. Rosario V, Science 1981 212 1037 1038 (Pubitemid 11078016)
16. Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Thaithong S, Beale GH, Fenton B, McBride J, Rosario V, Walker A, Walliker D, Trans R Soc Trop Med Hyg 1984 78 242 245
17. Adaptation of a strain of Plasmodium falciparum from Ghana to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys. Sullivan JS, Sullivan JJ, Williams A, Grady KK, Bounngaseng A, Huber CS, Nace D, Williams T, Galland GG, Barnwell JW, Collins WE, Am J Trop Med Hyg 2003 69 593 600 (Pubitemid 38248229)
18. Plasmodium falciparum: effect of time in continuous culture on binding to human endothelial cells and amelanotic melanoma cells. Udeinya IJ, Graves PM, Carter R, Aikawa M, Miller LH, Exp Parasitol 1983 56 207 214 (Pubitemid 14240042)
19. Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Thaithong S, Beale GH, Trans R Soc Trop Med Hyg 1981 75 271 273
20. Clinical drug-resistant falciparum malaria acquired from cultured parasites. Jensen JB, Capps TC, Carlin JM, Am J Trop Med Hyg 1981 30 523 525 (Pubitemid 11074925)
21. Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Oduola AM, Milhous WK, Weatherly NF, Bowdre JH, Desjardins RE, Exp Parasitol 1988 67 354 360 (Pubitemid 19008843)
22. Chromosome size variation occurs in cloned Plasmodium falciparum on in vitro cultivation. Wellems TE, Oduola AMJ, Fenton B, Desjardins R, Panton LJ, do Rosario VE, Rev Bras Genét 1988 11 813 825
23. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Burkot TR, Williams JL, Schneider I, Trans R Soc Trop Med Hyg 1984 78 339 341
24. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Peterson DS, Milhous WK, Wellems TE, Proc Natl Acad Sci U S A 1990 87 3018 3022
25. Drug resistance of a strain of P.falciparum from Malaya. DeGowin RL, Powell RD, Am J Trop Med Hyg 1965 14 519 528
26. WHO, Antimalarial drug combination therapy. Report of a WHO technical consultation [ http://www.who.int/malaria/publications/atoz/who-cds-rbm-2001-35/ en/index.html ]
27. The clinical efficacy of artemether/lumefantrine (Coartem). Makanga M, Krudsood S, Malar J 2009 8 Suppl 1 5
28. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620
29. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467
30. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM, Lancet Infect Dis 2012 12 851 858
31. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966
32. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Lindegardh N, Tarning J, Imwong M, Jacob CG, Rasmussen C, Perin J, Ringwald P, Nyunt MM, PLoS One 2013 8 57689
33. Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q, J Infect Dis 2010 202 1362 1368
34. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D, Antimicrob Agents Chemother 2013 57 914 923
35. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Gadalla NB, Adam I, Elzaki SE, Bashir S, Mukhtar I, Oguike M, Gadalla A, Mansour F, Warhurst D, El-Sayed BB, Sutherland C, Antimicr Agents Chemother 2011 55 5408 5411
36. Artemisinin resistance in rodent malaria-mutation in the AP2 adaptor mu-chain suggests involvement of endocytosis and membrane protein trafficking. Henriques G, Martinelli A, Rodrigues L, Modrzynska K, Fawcett R, Houston DR, Borges ST, d' Alessandro U, Tinto H, Karema C, Hunt P, Cravo P, Malar J 2013 12 118
37. The European Malaria Reagent Repository http://www.malariaresearch.eu/
38. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Corbett Y, Herrera L, Gonzalez J, Cubilla L, Capson TL, Coley PD, Kursar TA, Romero LI, Ortega-Barria E, Am J Trop Med Hyg 2004 70 119 124 (Pubitemid 38200513)
39. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S, Trans R Soc Trop Med Hyg 1999 93 369 374 (Pubitemid 29405860)
40. Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Gadalla NB, Elzaki SE, Mukhtar E, Warhurst DC, El-Sayed B, Sutherland CJ, Malar J 2010 9 74
41. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. Sutherland CJ, Haustein T, Gadalla N, Armstrong M, Doherty JF, Chiodini PL, J Antimicrob Chemother 2007 59 1197 1199 (Pubitemid 47073334)
42. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Humphreys GS, Merinopoulos I, Ahmed J, Whitty CJ, Mutabingwa TK, Sutherland CJ, Hallett RL, Antimicrob Agents Chemother 2007 51 991 997 (Pubitemid 46355285)
43. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C, Antimicrob Agents Chemother 2003 47 1347 1354 (Pubitemid 36368596)
44. Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom. Sutherland CJ, Fifer H, Pearce RJ, bin Reza F, Nicholas M, Haustein T, Njimgye-Tekumafor NE, Doherty JF, Gothard P, Polley SD, Chiodini PL, Antimicrob Agents Chemother 2009 53 3405 3410
45. Methods in Malaria Research. Moll K, Ljungstrom I, Perlmann H, Scherf A, Wahlgren M, Update version 5.2; 2009. http://www.mr4.org/Publications/ MethodsinMalariaResearch.aspx
46. Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients. Robinson T, Campino SG, Auburn S, Assefa SA, Polley SD, Manske M, MacInnis B, Rockett KA, Maslen GL, Sanders M, Quail MA, Chiodini PL, Kwiatkowski DP, Clark TG, Sutherland CJ, PLoS One 2011 6 23204
47. Synchronised cluster of falciparum malaria cases in an airport departure lounge. Rodger A, Cooke GS, Ord R, Sutherland CJ, Pasvol G, Emerging Infect Dis 2008 14 1284 1286
48. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Ringwald P, Bickii J, Basco LK, Am J Trop Med Hyg 1996 55 254 258 (Pubitemid 26321827)
49. Dihydrofolate reductase and antifolate resistance in malaria. Sirawaraporn W, Drug Resist Updat 1998 1 397 406
50. Residual Plasmodium falciparum parasitaemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, Omar SA, Shekalaghe SA, Kaur H, Ndaro A, Chilongola J, Schallig HD, Sauerwein RW, Hallett RL, Bousema T, J Infect Dis in press
51. The perils of PCR: can we accurately 'correct' antimalarial trials? Juliano JJ, Gadalla N, Sutherland CJ, Meshnick SR, Trends Parasitol 2010 26 119 124
52. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Klonis N, Xie SC, McCaw JM, Crespo-Ortiz MP, Zaloumis SG, Simpson JA, Tilley L, Proc Natl Acad Sci USA 2013 110 5157 5162
53. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. Sisowath C, Petersen I, Veiga MI, Martensson A, Premji Z, Bjorkman A, Fidock DA, Gil JP, J Infect Dis 2009 199 750 757
54. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ, Nature 2002 418 320 323 (Pubitemid 34790681)
55. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE, Proc Natl Acad Sci U S A 2009 106 18883 18889
56. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, Targett G, Drakeley CJ, Sutherland CJ, J Infect Dis 2007 196 1613 1619 (Pubitemid 351411958)
57. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Duraisingh MT, Roper C, Walliker D, Warhurst DC, Mol Microbiol 2000 36 955 961 (Pubitemid 30326539)
58. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF, Nature 2000 403 906 909 (Pubitemid 30130994)
59. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Sidhu AB, Valderramos SG, Fidock DA, Mol Microbiol 2005 57 913 926 (Pubitemid 41139856)
60. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Cooper RA, Ferdig MT, Su XZ, Ursos LM, Mu J, Nomura T, Fujioka H, Fidock DA, Roepe PD, Wellems TE, Mol Pharmacol 2002 61 35 42 (Pubitemid 34049510)
61. In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem). Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A, Gil JP, J Infect Dis 2005 191 1014 1017 (Pubitemid 40349821)
62. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. Baliraine FN, Rosenthal PJ, J Infect Dis 2011 204 1120 1124
63. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, Bull P, Marsh K, Borrmann S, Nzila A, Antimicrob Agents Chemother 2009 53 5069 5073
64. The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003. Mungthin M, Suwandittakul N, Chaijaroenkul W, Rungsrihirunrat K, Harnyuttanakorn P, Seugorn A, Na Bangchang K, Parasitol Res 2010 107 539 45
65. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro. Elueze EI, Croft SL, Warhurst DC, J Antimicrob Chemother 1996 37 511 518 (Pubitemid 26116966)
66. Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum. Pradines B, Briolant S, Henry M, Oeuvray C, Baret E, Amalvict R, Didillon E, Rogier C, Malar J 2010 9 339
67. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Foote SJ, Galatis D, Cowman AF, Proc Natl Acad Sci U S A 1990 87 3014 3017
68. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM, Trends Parasitol 2001 17 582 588 (Pubitemid 34088118)
69. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM, Acta Trop 2005 95 183 193 (Pubitemid 41207281)